Goldman Sachs Ups Stake in MorphoSys AG
Company Announcements

Goldman Sachs Ups Stake in MorphoSys AG

Morphosys Ag (MOR) has released an update.

MorphoSys AG has announced a significant shift in share ownership, reporting that The Goldman Sachs Group, Inc. has increased its voting rights in the company. As of the 13th of May, 2024, Goldman Sachs now holds a combined total of 15.67% in voting rights and instruments, marking a considerable rise from the previous notification. This change in the shareholder structure could have notable implications for MorphoSys AG’s strategic direction and governance.

For further insights into MOR stock, check out TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistIs MOR a Buy, Before Earnings?
TipRanks Auto-Generated NewsdeskMorphoSys AG Finalizes Delisting After Novartis Acquisition
TheFlyOxford Biomedica CFO Stuart Paynter to step down, Lucinda Crabtree to succeed
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App